港交所(00388.HK)旗下LME司法覆核判決被Elliott提上訴 LME將積極抗辯
港交所(00388.HK)公布,有關涉及附屬公司的法律程序,其全資附屬公司倫敦金屬交易所(LME)和LME Clear在原告人Elliott及Jane Street分別提出的申索中成為被告人。這些申索試圖挑戰LME所作出的有關取消原告人聲稱於2022年3月8日英國時間零時零分或之後執行的鎳合約交易的決定。
法院於2023年11月29日就司法覆核作出判決,被告人獲法院判全面勝訴。此公告指出,Elliott申請並獲批准就該判決向英國上訴法院提出上訴,上訴聆訊的時間現在尚未確定。LME和LME Clear認為該上訴毫無法律依據並將積極抗辯。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.